Evaluation of the efficacy and safety of intra-articular etanercept in patients with refractory knee joint synovitis: a placebo controlled, single-blind, crossover-trial, with randomisation of treatment sequence

Trial Profile

Evaluation of the efficacy and safety of intra-articular etanercept in patients with refractory knee joint synovitis: a placebo controlled, single-blind, crossover-trial, with randomisation of treatment sequence

Completed
Phase of Trial: Phase II

Latest Information Update: 13 Jun 2009

At a glance

  • Drugs Etanercept (Primary)
  • Indications Psoriatic arthritis; Rheumatoid arthritis; Spondylarthritis; Synovitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Jun 2009 Results were reported at the 10th Annual Congress of the European League Against Rheumatism.
    • 06 Jun 2008 New trial record.
    • 11 Nov 2007 Interim results in 25 patients presented at ACR 2007.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top